WallaceDC, SinghG, LottMT, et al.Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988; 242:1427–1430. DOI: 10.1126/science.3201231.
2.
WallaceDC, ZhengXX, LottMT, et al.Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell. 1988; 55:601–610. DOI: 10.1016/0092-8674(88)90218-8.
3.
ShoffnerJM, LottMT, LezzaAM, SeibelP, BallingerSW, WallaceDC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell. 1990; 61:931–937. DOI: 10.1016/0092-8674(90)90059-n.
4.
MITOMAP. A Human Mitochondrial Genome Database. www.mitomap.org (last accessed August3, 2020).
5.
MokBY, de MoraesMH, ZengJ, et al.A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. Nature. 2020; 583:631–637. DOI: 10.1038/s41586-020-2477-4.
6.
GormanGS, SchaeferAM, NgY, et al.Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol. 2015; 77:753–759. DOI: 10.1002/ana.24362.
7.
Rebolledo-JaramilloB, SuMS, StolerN, et al.Maternal age effect and severe germ-line bottleneck in the inheritance of human mitochondrial DNA. Proc Natl Acad Sci USA. 2014; 111:15474–15479. DOI: 10.1073/pnas.1409328111.
8.
MishmarD, Ruiz-PesiniE, BrandonM, WallaceDC. Mitochondrial DNA-like sequences in the nucleus (NUMTs): insights into our African origins and the mechanism of foreign DNA integration. Hum Mutat. 2004; 23:125–133. DOI: 10.1002/humu.10304.
9.
Ruiz-PesiniE, MishmarD, BrandonM, ProcaccioV, WallaceDC. Effects of purifying and adaptive selection on regional variation in human mtDNA. Science. 2004; 303:223–226. DOI: 10.1126/science.1088434.
10.
WallaceDC.Mitochondrial DNA variation in human radiation and disease. Cell. 2015; 163:33–38. DOI: 10.1016/j.cell.2015.08.067.
BacmanSR, WilliamsSL, HernandezD, MoraesCT. Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a ‘differential multiple cleavage-site’ model. Gene Ther. 2007; 14:1309–1318. DOI: 10.1038/sj.gt.3302981.
14.
BacmanSR, WilliamsSL, GarciaS, MoraesCT. Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease. Gene Ther. 2010; 17:713–720. DOI: 10.1038/gt.2010.25.
15.
BacmanSR, WilliamsSL, DuanD, MoraesCT. Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonuclease. Gene Ther. 2012; 19:1101–1106. DOI: 10.1038/gt.2011.196.
16.
BacmanSR., WilliamsSL, PintoM, PeraltaS, MoraesCT.Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nature Med. 2013; 19:1111–1113. DOI: 10.1038/nm.3261.
17.
BacmanSR, KauppilaJHK, PereiraCV, et al.MitoTALEN reduces mutant mtDNA load and restores tRNA(Ala) levels in a mouse model of heteroplasmic mtDNA mutation. Nature Med. 2018; 24:1696–1700. DOI: 10.1038/s41591-018-0166-8 (2018).
18.
LeeC, YenK, CohenP. Humanin: a harbinger of mitochondrial-derived peptides?. Trends Endocrinol Metab. 2013; 24:222–228. DOI: 10.1016/j.tem.2013.01.005.
19.
LeeC, ZengJ, DrewBG, et al.The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015; 21:443–454. DOI: 10.1016/j.cmet.2015.02.009.
20.
FayzulinRZ, , PerezM, KozhukharN, SpadaforaD, WilsonGL, AlexeyevMF. A method for mutagenesis of mouse mtDNA and a resource of mouse mtDNA mutations for modeling human pathological conditions. Nucleic Acids Res. 2015; 43:e62. DOI: 10.1093/nar/gkv140.
21.
TrifunovicA, WredenbergA, FalkenbergM, et al.Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 2004; 429:417–423. DOI: 10.1038/nature02517.
22.
KujothGC, HionaA, PughTD, et al.Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. 2005; 309:481–484. DOI: 10.1126/science.1112125.
23.
StewartJB, FreyerC, ElsonJL, et al.Strong purifying selection in transmission of mammalian mitochondrial DNA. PLoS Biol. 2008; 6:e10. DOI: 10.1371/journal.pbio.0060010.
24.
WisemanA, AttardiG. Reversible tenfold reduction in mitochondria DNA content of human cells treated with ethidium bromide. Mol Gen Genet. 1978; 167:51–63. DOI: 10.1007/BF00270321.
25.
StewartJB, FreyerC, ElsonJL, LarssonNG. Purifying selection of mtDNA and its implications for understanding evolution and mitochondrial disease. Nat Rev Genet. 2008; 9:657–662. DOI: 10.1038/nrg2396.
26.
FanW, WaymireKG, NarulaN, et al.A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science. 2008; 319:958–962. DOI: 10.1126/science.1147786.
